A phase 1/2, open-label study evaluating twice-daily...

Haematologica 2017 / 01 Vol. 102; Iss. 1

A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis

Gupta, Vikas, Mesa, Ruben A., Deininger, Michael W.N., Rivera, Candido E., Sirhan, Shireen, Brachmann, Carrie Baker, Collins, Helen, Kawashima, Jun, Xin, Yan, Verstovsek, Srdan
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
102
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2016.148924
Date:
January, 2017
File:
PDF, 1.28 MB
english, 2017
Conversion to is in progress
Conversion to is failed